AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
94,300
Employees94,300
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1992
Founded1992
Employees
94,300
Employees94,300

AZN Key Statistics

Market cap
221.24B
Market cap221.24B
Price-Earnings ratio
28.64
Price-Earnings ratio28.64
Dividend yield
2.12%
Dividend yield2.12%
Average volume
4.30M
Average volume4.30M
High today
$71.47
High today$71.47
Low today
$70.50
Low today$70.50
Open price
$70.99
Open price$70.99
Volume
2.73M
Volume2.73M
52 Week high
$87.68
52 Week high$87.68
52 Week low
$61.24
52 Week low$61.24

AZN News

TipRanks 15h
AstraZeneca’s SERENA-1 Study: A New Hope for Advanced Breast Cancer Treatment

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Ele...

TipRanks 15h
AstraZeneca’s Acalabrutinib Study: A Potential Game-Changer in Cancer Treatment

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Ele...

TipRanks 15h
AstraZeneca’s NASH Study Update: Key Insights for Investors

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Don...

Analyst ratings

90%

of 30 ratings
Buy
90%
Hold
10%
Sell
0%

More AZN News

TipRanks 15h
AstraZeneca’s Latest Clinical Study on Inhaler Propellants: Key Insights for Investors

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Ele...

TipRanks 15h
AstraZeneca’s Phase I Study on Selumetinib: Food’s Impact on Treatment for NF1

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Don...

TipRanks 2d
AstraZeneca’s Real-World Study of Koselugo: Key Insights for Investors

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Don...

TipRanks 2d
AstraZeneca price target raised to $97 from $93 at Berenberg

Berenberg analyst Luisa Hector raised the firm’s price target on AstraZeneca (AZN) to $97 from $93 and keeps a Buy rating on the shares. The firm increased its...

TipRanks 3d
‘Rare Buy Signal’ Sparks Reversal Hopes in AstraZeneca Stock

Despite a rough outing in the market to start off the week, multinational pharmaceutical and biotechnology giant AstraZeneca (AZN) managed to move the needle in...

Benzinga 3d
Artelo Biosciences Analyst See It As An Emerging Biotech

D. Boral Capital upgraded Artelo Biosciences, Inc. ARTL on Tuesday. The analyst upgraded from Hold to Buy and introduced a price forecast of $20. Analyst Jaso...

Artelo Biosciences Analyst See It As An Emerging Biotech
Simply Wall St 5d
Why Summit Therapeutics Is Up After AstraZeneca Licensing Talks For Cancer Drug

Summit Therapeutics has entered advanced negotiations with AstraZeneca for the potential licensing of its experimental lung cancer drug, ivonescimab, in a deal...

Why Summit Therapeutics Is Up After AstraZeneca Licensing Talks For Cancer Drug
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.